News|Articles|July 9, 2026
Eyes on June 2026: Approvals, pipeline momentum, and AI under the microscope
Author(s)Ophthalmology Times Staff Reports
Fact checked by: Martin David Harp
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
June delivered a busy slate across Ophthalmology Times, from a fresh FDA approval and a wave of pipeline milestones to a sharper look at where artificial intelligence helps clinicians and where it still falls short. Here are the stories worth your time this month.
Advertisement
Advertisement